• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Back to Resource Hub Article

How Digital Tech and Remote Assessments Aid Clinical Trials

Signant Health
Mar 7, 2025
Article

Originally published in Applied Clinical Trials

The COVID-19 pandemic disrupted clinical trials worldwide, ushering in a new digital reality for clinical research. Remote visits, telemedicine, and decentralized models are now essential for patient safety and trial continuity.

This article explores how digital technologies, including ePROs, wearables, and BYOD strategies, have become integral to modern trials, enabling data collection and patient engagement from remote locations.

READ THE ARTICLE

Similar posts

Looking for more insights? Explore related resources.

WHITE PAPER

Overcoming Data Quality Challenges During COVID-19

READ THE PAPER
WHITE PAPER

Mixing Patient-Reported Outcome Modes During COVID-19

DOWNLOAD
CASE STUDY

Signant SmartSignals Unified Platform Serves as an eSource for a COVID Treatment Trial 

READ THE STUDY

Get notified on new marketing insights

Here mention the benefits of subscribing